About Careers MedBlog Contact us

Methylated DNA Markers to be Used as Non-invasive Cancer Screening Method

by Julia Samuel on April 23, 2015 at 11:36 AM
Font : A-A+

Methylated DNA Markers to be Used as Non-invasive Cancer Screening Method

Analysing DNA markers from tumors can now be helpful to identify cancer in gastrointestinal tracts. A non-invasive blood test or stool sample could mean greater convenience for patients and save lives through earlier diagnosis of cancer.

A team of Mayo Clinic researchers studied normal as well as patients with colon or pancreatic cancer. By collecting and identifying methylated DNA in a blood test, they were able to identify the presence and origin of the cancerous cells with about 80% accuracy.


"What's exciting about our discovery is that it allows us to stop thinking about screening organs and start thinking about screening people. We think, based on the data we have, that a blood test could work in the future," said Dr. Kisiel.

Finding and correctly identifying distinctive methylated DNA from the cancers in a blood or stool sample may change the organ-by-organ search for cancer. Dr. Kisiel said, "DNA methylation may be a way to fingerprint not only the tissues themselves, but also the different types of cancer that might arise in those tissues."

They hope that in the future patients might be able to submit a blood specimen and it can be analyzed for the presence and absence of cancer markers. And if they are present they will be able to determine the anatomic location of the tumor, or the organ from which it originates.

Dr. Kisiel's research applied specifically to the gastrointestinal tract. "We've not yet tested this concept in cancers throughout the entire body, but that is the next step," he said.

Source: Medindia


Recommended Reading

Latest Cancer News

Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
How Does New Drugs Work Together to Reduce Lung Tumors?
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.
New Combination Therapy Proves Effective Against Prostate Cancer
Combination treatment with TALZENNA and XTANDI was found to benefit prostate cancer patients, revealed study.
Can Vitamin A Rich Diet Help Reduce Pancreatitis Risk
In leukemia patients, reduced amounts of dietary vitamin A is associated with a higher risk and severity of pancreatitis.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Methylated DNA Markers to be Used as Non-invasive Cancer Screening Method Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests